| Literature DB >> 23682924 |
John Kiiru1, Patrick Butaye, Bruno M Goddeeris, Samuel Kariuki.
Abstract
BACKGROUND: We determined the prevalence and evidence for physical linkage amongst integrons, insertion sequences, Tn21 and Tn7 transposons in a collection of 1327 E. coli obtained over a 19-year period from patients in Kenya.Entities:
Mesh:
Year: 2013 PMID: 23682924 PMCID: PMC3663672 DOI: 10.1186/1471-2180-13-109
Source DB: PubMed Journal: BMC Microbiol ISSN: 1471-2180 Impact factor: 3.605
Susceptibility profiles of isolates and their distribution in various specimen-types obtained from different categories of patients
| | | | |||||
|---|---|---|---|---|---|---|---|
| 756 | 57 | 225 (30) | 355 (57) | 176 (23) | 439 (58) | 318 (42) | |
| 809 | 61 | 253 (31) | 373 (46) | 184 (23) | 518 (64) | 292 (36) | |
| 478 | 36 | 143 (30) | 249 (52) | 86 (18) | 329 (69) | 148 (31) | |
| 544 | 41 | 153 (28) | 288 (53) | 103 (19) | 343 (63) | 201 (37) | |
| 279 | 21 | 85 (30) | 141 (51) | 53 (19) | 226 (81) | 53 (19) | |
| 385 | 29 | 121 (31) | 191 (50) | 73 (19) | 258 (67) | 127 (33) | |
| 411 | 31 | 121 (29) | 256 (62) | 34 (8) | 234 (57) | 177 (43) | |
| 358 | 27 | 97 (27) | 184 (51) | 78 (22) | 266 (74) | 93 (26) | |
| 372 | 28 | 102 (27) | 197 (53) | 73 (19) | 290 (78) | 82 (22) | |
| 279 | 21 | 83 (30) | 142 (51) | 54 (19) | 201 (72) | 78 (28) | |
| 119 | 9 | 31 (26) | 76 (64) | 12 (10) | 99 (83) | 20 (17) | |
| 106 | 8 | 19 (18) | 79 (74) | 8 (6) | 87 (82) | 19 (18) | |
| 239 | 18 | 86 (36) | 132 (55) | 21 (9) | 163 (68) | 77 (32) | |
| 106 | 8 | 19 (18) | 79 (75) | 8 (8) | 65 (61) | 41 (39) | |
| 491 | 37 | 145 (30) | 271 (55) | 75 (15) | 290 (59) | 201 (41) | |
| 305 | 23 | 85 (28) | 167 (55) | 53 (17) | 195 (64) | 110 (36) | |
| 239 | 18 | 71 (30) | 131 (54) | 37 (16) | 170 (71) | 69 (29) | |
| 212 | 16 | 71 (34) | 120 (56) | 21 (10) | 174 (82) | 38 (18) | |
| 385 | 29 | 89 (23) | 254 (66) | 42 (11) | 277 (72) | 108 (28) | |
| 478 | 36 | 167 (35) | 233 (49) | 78 (16) | 320 (67) | 158 (33) | |
| 637 | 48 | 189 (30) | 356 (56) | 92 (14) | 440 (69) | 197 (31) | |
| 703 | 53 | 218 (31) | 353 (50) | 132 (19) | 478 (68) | 225 (32) | |
| 557 | 42 | 167 (30) | 290 (52) | 100 (18) | 379 (68) | 178 (32) | |
The distribution of resistant strains in different specimen-types obtained from inpatients and outpatients. The percentages are calculated based on the total number of strains resistant to a given antimicrobial in different specimen types and category of patients. AMOX: amoxicillin, AMP: ampicillin, AMC: amoxicillin-clavulanic acid, AMS: ampicillin-sulbactam, TZP: piperacillin-tazobactam, AZT: Aztreonam, CEF: cefuroxime, CRO: ceftriaxone, CTX: cefotaxime, CAZ: ceftazidime, FEP: cefepime, FOX: cefoxitin, NA: nalidixic acid, CIP: ciprofloxacin, STRP: streptomycin, K: kanamycin, CN: gentamicin, NEO: neomycin, F: nitrofurantoin, C: chloramphenicol, SUL: sulfamethoxazole, TET: Tetracylines, TRIM: Trimethoprim.
Distribution of isolates exhibiting combined resistance to selected antimicrobials
| SUL, TRIM, CIP + CN + FEP + FOX + TZP and aminoglycosides a | 106 | 30 (28) | 57 (54) | 19 (18) | 87 (82) | 19 (18) |
| F + SUL + TRIM + TET + Cb | 451 | 121 (27) | 233 (52) | 97 (22) | 322 (71) | 129 (29) |
| AMC + AMSc | 411 | 125 (30) | 218 (53) | 68 (17) | 255 (62) | 156 (38) |
| AMS + AMC + TZPc | 291 | 87 (30) | 172 (59) | 32 (11) | 194 (67) | 97 (33) |
| ESBL strains | 272 | 95 (35) | 133 (49) | 44 (16) | 188 (69) | 84 (31) |
| Isolates with an AmpC-like phenotype | 122 | 38 (31) | 72 (59) | 12 (10) | 93 (76) | 29 (24) |
Distribution of strains resistant to different combinations of antimicrobials among different specimen-types obtained from inpatient and outpatients. CIP: ciprofloxacin, CN: gentamicin, FEP: cefepime, FOX: cefoxitin, TET: tetracyclines, TZP: piperacillin-tazobactam, F: nitrofurantoin, SUL: sulfamethoxazole, TRIM: Trimethoprim, C: chloramphenicol, AMC: amoxicillin-clavulanic, AMS: ampicillin-sulbactam.
ESBL strains are susceptible to AMC and cephamycins but resistant to various combinations of cephalosporins while isolates with an AmpC-like phenotype are resistant to cephalosporins and cephamycins.
a: Isolates were resistant to at least one aminoglycoside.
b: These antimicrobials are relatively cheap and are readily available in developing countries.
c: Combinations of β-lactamase inhibitors that may be used to treat infections caused by strains that are resistant to β-lactams.
Diversity of cassette arrays detected among class 1 and class 2 integrons
| | |||||
|---|---|---|---|---|---|
| | | | | | |
| 2 to 4 | 60 (13) | 53 (88) | 7 (12) | ||
| 5 to 8 | 51 (11) | 42 (82) | 9 (18) | ||
| 5 to 8 | 42 (9) | 34 (81) | 8 (19) | ||
| 2 to 8 | 42 (9) | 35 (83) | 7 (17) | ||
| 2 to 6 | 23 (5) | 19 (83) | 4 (17) | ||
| 4 to 8 | 23 (5) | 19 (83) | 4 (17) | ||
| 6 to 8 | 23 (5) | 22 (96) | 1 (4) | ||
| 3 to 6 | 28 (6) | 26 (93) | 2 (7) | ||
| 3 to 8 | 23 (5) | 22 (96) | 1 (4) | ||
| 7 to 8 | 23 (5) | 22 (96) | 1(4) | ||
| 8 | 23 (5) | 22 (94) | 1 (4) | ||
| 7 to 8 | 9 (2) | 8 (88) | 1 (12) | ||
| 6 to 8 | 9 (2) | 8 (88) | 1 (12) | ||
| CN | 5 to 8 | 9 (2) | 7 (78) | 2 (22) | |
| 3 to 8 | 9 (2) | 9 (100) | 0 | ||
| CN, | 8 | 9 (2) | 2 (22) | 7 (78) | |
| 7 to 8 | 5 (1) | 4 (80) | 1 (20) | ||
| 3 to 8 | 3 (<1) | 3 (100) | 0 | ||
| 6 | 3 (<1) | 0 | 3 (100) | ||
| 8 | 5 (1) | 0 | 5 (100) | ||
| CN, | 8 | 42 (9) | 15 (36) | 27 (64) | |
| | | | | | |
| 6 to 8 | 3 (<1) | NA | NA | ||
The integron cassette arrays are indicated in the order they appear within class 1 and 2 integron variable cassette region (in the 5’-3’ orientation).
The resistance phenotype associated with a given array is indicated in bold.
a: Different antimicrobials tested in this study were conveniently grouped into 8 groups:- β-lactams and β-lactamase inhibitors, aminoglycosides, (fluoro)quinolones, nitrofurantoin, chloramphenicol, sulphonamides, trimethoprim, and tetracyclines.
b: These integrons carried a sul3 gene at the 3’-end or lacked this gene or 3’-CS comprising the qacEΔ1-sul1 genes.
Carriage of resistance genetic elements among 1327exhibiting resistance to different classes of antimicrobials
| | ||||||
|---|---|---|---|---|---|---|
| Integrons | 464 | 35 | 0 | 37 (8) | 65 (14) | 362 (78) |
| IS | 199 | 15 | 0 | 0 | 18 (9) | 181 (91) |
| ISE | 128 | 10 | 0 | 0 | 35 (27) | 93 (73) |
| IS | 86 | 7 | 0 | 0 | 12 (14) | 74 (86) |
| Tn | 289 | 22 | 0 | 18 (6) | 33 (11) | 238 (83) |
| Tn | 3 | <1 | 0 | 0 | 1 (25) | 2 (75) |
| | | | | | ||
| Integron + IS | 38 | 3 | 0 | 0 | 2 (5) | 36 (95) |
| Integron + IS | 28 | 2 | 0 | 0 | 2 (7) | 26 (93) |
| Integron + IS | 16 | 1 | 0 | 0 | 0 | 16 (100) |
| No genetic element detected | 332 | 35 | 307 (93) | 25 (6) | 0 | 0 |
Carriage of genetic elements or combination of elements among strains exhibiting resistance to different antimicrobials tested in this study. The antimicrobials were grouped into 8 convenient groups:- β-lactams and β-lactamase inhibitors, aminoglycosides, (fluoro)quinolones, nitrofurantoin, chloramphenicol, sulphonamides, trimethoprim, and tetracyclines.
Figure 1Schematic diagram showing some of the strategies for screening for various genetic elements and for interrogation between these elements and resistance genes. The targets of each primer and the direction of PCR amplification is shown using arrows. PCRs were done both in the 5’ and in the 3’ orientation for each pair of genes tested. A: The strategy used for detection and characterization of class 1 integrons. B: The strategy used for detection and characterization of class 2 integrons and their physical linkage to Tn7. C: An example of the strategy used for analysis of physical linkages between class 1 integrons and Tn21 and to IS26. The primer positions for screening of Tn21 transposition genes. D and E: An example of the strategy used for analysis for physical linkages between integrons, ISCR1 and bla genes. F: An example of the strategy used for analysis for physical linkages between integrons, ISEcp1, IS26 and bla genes. These illustrations are based on PCR mapping data and not sequencing. Therefore, the sizes of each gene and the distances between any two genes are not drawn to scale.
Figure 2Schematic diagram illustrating examples of physical linkages amongst genetic elements and selected genes. 1a-1f: An example of physical linkages between bla genes and multiple genetic elements such as integrons, ISEcp1, and IS26. 2a-2b: An example of physical linkages between bla genes and ISEcp1. 3a-3d: An example of physical linkages between integrons and other genetic elements (such as the ISCR1 element) that are in turn linked to bla genes and (fluoro)quinolone resistant genes. 4a-4c: An example of physical linkages between Tn21 and integrons that are in turn be linked to IS elements. These illustrations are based on PCR mapping data and not sequencing. Therefore, the sizes of each gene and the distances between any two genes are not drawn to scale.
Physical linkages between integrons and other genetic elements
| | | |||||
|---|---|---|---|---|---|---|
| Class 1 integrons with 3‘-CS | 375 | 3 (1) | 257 (69) | 199 (53) | 19 (5) | 4 (1) |
| Class 1 integron with | 64 | 0 | 12 (19) | 0 | 12 (19) | 48 (75) |
| Class 1 integrons lacking 3’-CS or | 25 | 0 | 5 (20) | 0 | 10 (40) | 20 (80) |
| Class 2 integron | 3 | 3 (100) | 1 (33) | 1 (33) | 1 (33) | 0 |
Carriage of Tn21, Tn7 and IS elements among strains carrying class 1 integrons. Carriage of other genetic elements among strains carrying class 2 integrons is also shown.
Carriage of transposition genes among Tntransposons
| | | |||
|---|---|---|---|---|
| Tn | 156 | 0 | 9 (6) | 147 (94) |
| Tn | 133 | 56 (42) | 63 (47) | 14 (11) |
PCR methods were used for screening for three genes that are crucial for transposition of Tn21. The tnpA encodes a Tn21-like transposase, the tnpM encodes a putative transposition regulator. Integrons are incorporated into the Tn21 framework adjacent to the tnpM gene. The tnpR encodes a resolvase.
Analysis for physical association betweengenes and various genetic elements
| | | ||||
|---|---|---|---|---|---|
| 60 | 23 (38) | 12 (20) | 10 (17) | 9 (15) | |
| 43 | 12 (28) | 21 (49) | 32 (74) | 36 (84) | |
| 17 | 0 | 2 (12) | 5 (29) | 3 (18) | |
| 18 | 10 (55) | 5 (28) | 3 (17) | 1 (6) | |
| 19 | 7 (37) | 4 (21) | 3 (16) | 2 (11) | |
| 9 | 1 (11) | 0 | 2 (22) | 1 (11) | |
| 15 | 6 (40) | 0 | 0 | 0 | |
| 6 | 2 (33) | 1 (17) | 0 | 0 | |
| 3 | 0 | 1 (33) | 3 (100) | 0 | |
| 25 | 10 (40) | 3 (12) | 5 (20) | 3 (12) | |
| 32 | 4 (13) | 30 (94) | 0 | 0 | |
| 18 | 2 (11) | 0 | 1 (6) | 1 (6) | |
| 9 | 0 | 0 | 0 | 0 | |
| 10 | 2 (20) | 1 (10) | 6 (60) | 3 (30) | |
| 37 | 29 (78) | 1 (3) | 3 (8) | 2 (5) | |
| 9 | 2 (22) | 0 | 3 (33) | 2 (22) | |
| 36 | 3 (8) | 0 | 3 (8) | 2 (6) | |
| 14 | 1 (7) | 0 | 4 (29) | 2 (14) | |
| 10 | 1 (10) | 0 | 0 | 0 | |
| 48 | 12 (25) | 42 (88) | 12 (25) | 3 (6) | |
Analysis for physical linkages between bla genes and various genetic elements. The bla content of the isolates analyzed had been determined in a past study [3].
Carriage ofandgenes among strains containing genetic elements andgenes
| | | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 42 | 42 (100) | 42 (100) | 6 (14) | 4 (9) | 12 (29) | 6 (14) | 11 (26) | 4 (10) | 0 | 4 (9) | 38 (91) | |
| 34 | 27 (79) | 26 (75) | 11 (32) | 4 (12) | 28 (82) | 23 (68) | 8 (24) | 1 (3) | 0 | 2 (6) | 32 (94) | |
| 19 | 19 (100) | 11 (58) | 10 (53) | 2 (11) | 13 (64) | 4 (21) | 12 (63) | 1 (5) | 0 | 1 (5) | 18 (95) | |
Table shows the number of isolates carrying the three (fluoro)quinolone resistance genes and the proportion of such strains in which these genes were physically linked to various genetic elements and to bla genes.
a: Distribution of the aac(6’)-lb-cr and qnr genes among strains fully susceptible to β-lactams, among those resistant to TEM-1 or SHV-1 with a narrow substrate-range and among those carrying genes encoding broad-spectrum β-lactamases such as bla, bla, bla and bla.
Horizontal transfer of genetic elements and associated resistance genes from clinical strains (donors) to(recipient)
| P, | |||
| IS | A/C, | ||
| i | |||
| AMP, CTX, CAZ, NA, CIP, | intI1/ | I1, | |
| FIA, | |||
| AMP, CTX, NA, CIP, | FIB, F, | ||
| FIB, | |||
Table shows carriage of genetic elements and selected genes conferring resistance to important classes of antimicrobials. The resistance phenotype and the genetic elements or genes transferred to the transconjugants are indicated in bold.
Primers for screening for genetic elements and resistance genes and for analysis for physical linkages among such elements and selected resistance genes
| | | | | | |
| INT-1 F | GTTCGGTCAAGGTTCTG | 50 | 923 | U12338 | |
| INT-1R | GCCAACTTTCAGCACATG | ||||
| INT-2 F | ATGTCTAACAGTCCATTTT | 50 | 450 | AJ001816.1 | |
| INT-2R | AAATCTTTAACCCGCAAAC | ||||
| INT3-F | GCAGGGTGTGGACGAATACG | 57 | 760 | AY219651 | |
| INT3-R | ACAGACCGAGAAGGCTTATG | ||||
| 3'-CS | qacED1 | ATCGCAATAGTTGGCGAAGT | 56 | 800 | X15370 |
| sul1-B | GCAAGGCGGAAACCCGCGCC | X12869 | |||
| integron class 1 VCR | In-F | GGCATACAAGCAGCAAGC | 52 | Variable | U12338 |
| In-B | AAGCAGACTTGACCTGAT | ||||
| integron 2 VCR | hep74 | CGGGATCCCGGACGGCATGCACGATTTGTA | 55 | Variable | EU780012 |
| hep51 | GATGCCATCGCAAGTACGAG | AJ002782 | |||
| | | | | | |
| ISE | ISEcp1-F | GTT GCT CTG TGG ATA ACT TG | 55 | 180 | AJ242809 |
| ISEcp1-R | CCT AAA TTC CAC GTG TGT | ||||
| IS | ISCR1-F | CGC CCA CTC AAA CAA ACG | 55 | 469 | L06418 |
| ISCR1-R | GAG GCT TTG GTG TAA CCG | ||||
| IS | IS26-F | GCGGTAAATCGTGGAGTGAT | 55 | 704 | NC 007941.1 |
| IS26-R | ATTCGGCAAGTTTTTGCTGT | ||||
| | | | | | |
| TnpM-F | TCAACCTGACGGCGGCGA | 55 | 348 | AF071413 | |
| TnpM-R | GGAGGTGGTAGCCGAGG | ||||
| TnpR-F | GTC AGC AGC TTC GAC CAG AA | 62 | 500 | NC 002134.1 | |
| TnpR-R | GAG GTA CTG GTA GAG GGT TT | ||||
| TnpA21-F | TGC GCT CCG GCG ACA TCT GG | 62 | 1200 | NC 002134.1 | |
| TnpA21-R | TCA GCC CGG CAT GCA CGC G | ||||
| TnA7-F | CCCAGCAATAAAAGAGCTCATTGAGCAAGC | 55 | 738 | FJ914220.1 | |
| TnA7-R | TATCTAGAAACAGAGTGTCTTG | ||||
| | | | | ||
| qnrA-F | TTCAGCAAGAGGATTTCTCA | 55 | 627 | AY070235 | |
| qnrA-R | GGCAGCACTATTACTCCCAA | ||||
| qnrB-F | CCTGAGCGGCACTGAATTTAT | 60 | 408 | DQ351241 | |
| qnrB-R | GTTTGCTGCTCGCCAGTCGA | ||||
| qnrS-F | CAATCATACATATCGGCACC | 60 | 641 | AB187515 | |
| qnrS-R | TCAGGATAAACAACAATACCC | ||||
| aac(6′)-Ib-cr-F | TTGCGATGCTCTATGAGTGGCTA | 55 | 482 | AAL93141.1 | |
| aac(6′)-Ib-cr-R | CTCGAATGCCTGGCGTGTTT | ||||
| aac(6′)-Ib-cr (sequencing) | CGTCACTCCATACATTGCAA | | |||
| | | | | | |
| TEM-F | ATGAGTATTCAACAT TTC CG | 55 | 840 | EF125012 | |
| TEM-R | CCAATGCTTAATCAG TGA GG | ||||
| SHV-F | TTCGCCTGTGTATTATCTCCCTG | 50 | 854 | AF148850 | |
| SHV-R | TTAGCGTTGCCAGTGYTCG | ||||
| CTX-M-F | ATGTGCAGYACCAGTAARGTKATGGC | 60 | 593 | Y10278 | |
| CTX-m-R | TGGGTRAARTARGTSACCAGAAYCAGCGG | ||||
| CMY-F | ATGATGAAAAAATCGTTATGC | 55 | 1200 | U77414 | |
| CMY-R | TTGCAGCTTTTCAAGAATGCGC | ||||
| OXA-1 F | ATGAAAAACACAATACATATCAACTTCGC | 62 | 820 | JO2967 | |
| OXA-1R | GTGTGTTTAGAATGGTGATCGCATT | ||||
| OXA-2 F | ACGATAGTTGTGGCAGACGAAC | 62 | 602 | AF300985 | |
| OXA-2R | ATYCTGTTTGGCGTATCRATATTC | ||||
Primers used for screening various genetic elements and for interrogating physical linkages between different genetic elements and between such elements and bla genes or (fluoro)quinolone resistance genes.
Y = T or C, R = G or A, S = G or C, K = G or T.